SPARTEINE OXIDATION BY THE HUMAN-LIVER - ABSENCE OF INHIBITION BY MEPHENYTOIN

被引：27

作者：

JURIMA, M ^{[1
]}

INABA, T ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO,FAC MED,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 03期

关键词：

D O I：

10.1038/clpt.1984.54

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：426 / 428

页数：3

共 14 条

[1]

Dixon M., 1964, ENZYMES, P328

[2] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[3] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[4]

EICHELBAUM M, 1975, THESIS U BONN BONN

[5] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549

[6]

KUPFER A, 1979, PHARMACOLOGIST, V21, P173

[7]

KUPFER A, 1981, HEPATOLOGY, V81, P34

[8] POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].

MAHGOUB, A ;

IDLE, JR ;

DRING, LG ;

LANCASTER, R ;

SMITH, RL .

LANCET, 1977, 2 (8038) :584-586

[9] INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY TRICYCLIC ANTI-DEPRESSANTS AND OTHER DRUGS [J].

OTTON, SV ;

INABA, T ;

KALOW, W .

LIFE SCIENCES, 1983, 32 (07) :795-800

[10] INVITRO METABOLISM OF SPARTEINE BY HUMAN-LIVER - COMPETITIVE-INHIBITION BY DEBRISOQUINE [J].

OTTON, SV ;

INABA, T ;

MAHON, WA ;

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (01) :102-105

← 1 2 →